Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07128966

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

This study aims to help researchers better understand health conditions and develop improved tests, treatments, and cures for diseases. Joined Bio collects health data, lifestyle information, biological samples, and feedback from participants and provides this to qualified research partners.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Primary: The primary objective of this study is to connect participants with specific health profiles, along with biospecimens and associated de-identified health data, to scientific researchers who are searching for new diagnostics and treatments for a wide array of conditions. This will accelerate medical discovery by connecting medical research with the power of patient participation.

Secondary: The secondary objective of this study is to allow participants with specific health profiles, along with their de-identified health data, to help further the cause of medicine generally through interviews, surveys, and other minimal risk research activities desired by life science organizations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female, that are adults [have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico].
  • Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf.
  • Be willing to comply with all study procedures and be available for the duration of the study.
  • Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range).
  • Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B.

Exclusion criteria

  • Unable to meet the Inclusion Criteria listed above.
  • Prisoners or children
  • Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.

Treatment and study plan

observation

Other

This is non-interventional, observational only

Primary outcomes

  1. Observation for biomarker identification

    Time frame: 10 years

    There is no defined study outcome. Rather this is an observational study of multiple participant populations that hopes to identify new biomarkers, treatments and/or diagnostic applications.

Study contacts

Contact information is provided by the study sponsor or research team.

Emily L Hubbard, BS Biology

CONTACT

[email protected]

12567970003

Jill Mullan

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Joined Bio

Industry

Registry information

Official study title

Joined Bio - JB-MR-250225, Direct to Patient Minimal Risk Research

Acronym: JBMR

Important dates

Study start
2025
Primary completion
2035
Study completion
2036
First posted
Aug 19, 2025
Registry last updated
May 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.